Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

R&D Market Pulse: WHO to Create DNA-Editing Guidelines

By Tim Studt | February 26, 2019

The R&D Index for the holiday-shortened week ending February 22, 2019 closed at 4,348.28 for the 25 companies in the R&D Index. The Index was up 0.86% (or 37.26 basis points) from the week ending February 15, 2019. The stock of 20 R&D Index members gained value from 0.05% (Astra Zeneca) to 3.75% (Daimler). The stock of five R&D Index members lost value from -0.27% (Alphabet/Google) to -3.22% (Sanofi SA).

The Federal Reserve stated last week that it would consider changing its policy framework to encourage periods of modestly higher inflation. The Fed stated that consumers and businesses need to guard against anticipating low inflation, lest their expectations become self-fulfilling. The Fed’s 2.0% inflation target has been consistently undercut since 2021.

The World Health Organization (WHO) last week established a new committee to set scientific guidelines for editing DNA. The committee, which includes Chinese representatives, plans to meet in March to examine the scientific, ethical, social and legal challenges associated with editing human genes and make recommendations to the research community. These guidelines will create an understanding on how to promote transparency, accountability and risk assessments that should be made before signoffs are granted on DNA-based experiments. However, analysts state that the committee’s recommendations are not likely to be enforceable.

AT&T announced last week that it would discontinue support of 3G service in early 2022. The currently available 4G (or LTE) service allows users to download data 10 times faster than with 3G systems.

Increasing trade disparity data released last week between Asian countries such as Japan-China and Korea-China point to the declining economic growth in China. Analysts note that this data overwhelms any trade agreement that might be obtained between the U.S. and China. The only cure to the fading global growth malaise, according to analysts, lies in the success of China’s internal economic stimulus efforts.

R&D Index member Johnson & Johnson last week received subpoenas from the U.S. Justice Department seeking documents related to the safety of its talc powder. More than 13,000 lawsuits have now been filed against the company over the past several years citing ovarian cancer and mesothelioma injuries. The lawsuits claim J&J knew for decades that the talc contained cancer-causing asbestos, which was concealed from regulators.  

R&D Index Week Ending February 22, 2019

  Ticker Exchange 2018 R&D millions U.S. $ 02/15/19 02/22/19 2/22/19 to 2/15/19 2/22/19 to 12/31/18
Amazon AMZN NASDAQ 26,750 1,607.95 1,631.56 1.47% 8.63%
Alphabet/Google GOOGL NASDAQ 18,796 1,119.63 1,116.56 -0.27% 6.85%
Apple AAPL NASDAQ 14,037 170.42 172.97 1.50% 9.66%
Intel INTC NASDAQ 13,702 51.66 52.49 1.61% 11.85%
Microsoft MSFT NASDAQ 13,558 108.22 110.97 2.54% 9.25%
Roche Pharm RHHBY OTC 12,284 34.02 34.73 2.09% 11.74%
Johnson & Johnson JNJ NYSE 11,493 136.38 136.60 0.16% 5.85%
Merck & Co. MRK NYSE 11,323 79.81 80.77 1.20% 5.71%
Volkswagen AG VWAGY OTC 10,915 16.61 17.14 3.19% 9,87%
Toyota TM NYSE 10,848 121.15 121.82 0.55% 4.94%
Novartis NVS NYSE 8,934 89.88 90.78 1.00% 5.79%
Honda HMC NYSE 8,180 27.37 28.17 2.92% 6.50%
Pfizer PFE NYSE 7,942 42.40 42.96 1.32% -1.58%
Daimler DDAIY OTC 7,615 57.11 59.25 3.75% 12.28%
General Motors GM NYSE 7,278 39.09 39.99 2.30% 19.55%
Oracle ORCL NYSE 7,001 51.72 52.48 1.47% 16.23%
Bristol-Myers Squibb BMY NYSE 6,981 51.67 50.98 -1.34% -1.92%
Eli Lilly Co LLY NYSE 6,769 122.48 124.00 1.24% 7.16%
GlaxoSmithKline GSK NYSE 6,394 41.24 40.55 -1.67% 6.12%
Cisco CSCO NASDAQ 6,009 49.43 50.11 1.38% 15.65%
IBM IBM NYSE 5,842 138.03 139.25 0.88% 22.50%
Bayer AG BAYN OTC 5,743 19.30 18.91 -2.02% 7.63%
Astra Zeneca PLC AZN NYSE 5,483 40.92 40.94 0.05% 7.79%
Qualcomm QCOM NASDAQ 5,183 51.98 53.12 2.19% -6.64%
Sanofi SA SNY NYSE 4,694 42.55 41.18 -3.22% -5.14%
Total     243,754 4,311.02 4,348.28 0.86% 7.97%
               
    Biopharmaceutical 700.65 702.40 0.25% 4.70%
    Automotive 261.33 266.37 1.93% 9.01%
    ICT   1,741.09 1,747.95 0.45% 8.55%

About the R&D Index

R&D Magazine’s R&D Index is a weekly stock market summary of the top international companies involved in research and development. The top 25 industrial spenders of R&D in 2017 were selected based on the latest listings from Schonfeld & Associates’ June 2018 R&D Ratios & Budgets. These 25 companies include pharmaceutical (11 companies), automotive (5), ICT (8) and conglomerate (1) organizations who invested a cumulative total of more than $209 billion in R&D in 2017, or approximately 10% of all the R&D spent in the world by government, industries and academia combined, according to R&D Magazine’s 2019 Global R&D Funding Forecast. The stock prices used in the R&D Index are tabulated from NASDAQ, NYSE, XETRA and OTC common stock prices (in U.S. dollars) for the companies selected at the close of stock trading business on the Friday preceding the publication of the R&D Index in R&D Magazine’s R&D Daily eNewsletter.

Related Articles Read More >

FDA looks to ban nicotine in cigarettes, in this week’s R&D Power Index
Inflation may slow, but R&D still hot, in this week’s R&D Power Index
Inflation and responses will affect R&D plans, in this week’s R&D Power Index
R&D and inflation both increasing globally, in this week’s R&D Power Index
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2022 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars